The antifibrotic role of natural killer cells in liver fibrosis

Exp Biol Med (Maywood). 2022 Jul;247(14):1235-1243. doi: 10.1177/15353702221092672. Epub 2022 Apr 27.

Abstract

Liver fibrosis is the common pathological change of chronic liver diseases characterized by increased deposition of extracellular matrix and reduced matrix degradation. In response to liver injury caused by a variety of pathogenic agents, such as virus and alcohol, hepatic stellate cells (HSCs) are differentiated into myofibroblast-like cells and produce excessive collagens, thus resulting in fibrogenesis. Natural killer (NK) cells are the essential innate immune cells in the liver and generally control fibrosis by killing activated HSCs. This review briefly describes the fibrogenesis process and the phenotypic features of hepatic NK cells. Besides, it focuses on the antifibrotic mechanisms of NK cells and explores the potential of activating NK cells as a therapeutic strategy for the disease.

Keywords: Natural killer cells; apoptosis; fibrosis; hepatic stellate cells.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hepatic Stellate Cells / pathology
  • Humans
  • Killer Cells, Natural
  • Liver / metabolism
  • Liver Cirrhosis* / pathology
  • Liver Diseases* / pathology